Agios Pharmaceuticals Inc. (AGIO)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity | Share change | % change to portfolio ▼ | |
| Q3 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 26,960 | 0.01 | |
| Q1 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 1270.17% | 3,747 | 0.00 | |
| Q4 2020 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 295 | 0.00 | |
| Q4 2018 | |||||
| ≡ | Meridian Contrarian Fund | Add 18.42% | 21,000 | 0.19 | |
| Q1 2018 | |||||
| ≡ | Leon Cooperman | Buy | 45,000 | 0.14 | |
| Q3 2017 | |||||
| ≡ | Meridian Contrarian Fund | Add 9.60% | 12,000 | 0.14 | |
| Q1 2017 | |||||
| ≡ | Meridian Contrarian Fund | Add 100.00% | 62,500 | 0.70 | |
| Q2 2016 | |||||
| ≡ | Meridian Contrarian Fund | Add 42.02% | 25,000 | 0.21 | |
| Q4 2015 | |||||
| ≡ | Meridian Contrarian Fund | Buy | 59,500 | 0.71 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.